MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Tendency towards being a “Morning person” increases risk of Parkinson’s disease: evidence from Mendelian randomisation

    A. Noyce, D. Kia, K. Heilbron, J. Jepson, G. Hemani, D. Hinds, D. Lawlor, G. Davey Smith, J. Hardy, A. Singleton, M. Nalls, N. Wood (London, United Kingdom)

    Objective: To explore the causal relationship between circadian rhythm and Parkinson's disease (PD), and coffee consumption and PD, using Mendelian randomisation (MR). Background: Circadian rhythm…
  • 2018 International Congress

    A nationwide epidemiological study of Parkinson’s disease in Korea using national health insurance database

    WW. Lee, B. Jeon, BK. Kim, HJ. Kim (Seoul, Republic of Korea)

    Objective: To investigate the incidences and prevalences, and those male-to-female ratios of PD patients in Korea. Background: The epidemiological studies of Parkinson’s disease (PD) are…
  • 2018 International Congress

    Droxidopa and Midodrine Treatment Persistence in Patients with Orthostatic Hypotension

    S. Kymes, K. Jackson, M. Widolff, C. Sullivan, L. Hewitt, S. Raj (Deerfield, IL, USA)

    Objective: To determine the treatment persistence of droxidopa and midodrine in patients with orthostatic hypotension (OH) or neurogenic orthostatic hypotension (nOH) when medication cost was…
  • 2018 International Congress

    Clinical Characteristics of Functional Movement Disorders: A Clinic-Based Study

    J. Park (Goyang, Republic of Korea)

    Objective: We aimed to determine the frequency of functional movement disorder patients at a university outpatient neurology clinic, and highlight the clinical and phenomenological characteristics.…
  • 2018 International Congress

    Emergency and in-patient healthcare utilization in Parkinson’s disease

    M. Mackenzie, G. Al Momen, A. Yu, K. Sundvick, J. Wright, A. Shiu, S. Appel-Cresswell (Vancouver, BC, Canada)

    Objective: To characterize healthcare resource utilization by people with PD by examining emergency room presentations and hospital admissions. Background: PD is a progressive neurodegenerative condition…
  • 2018 International Congress

    Prediction of suicidality in Huntington disease: Analysis of Enroll-HD data using machine learning approach

    Y. Seliverstov, A. Borzov, E. van Duijn, B. Landwehrmeyer, M. Belyaev (Moscow, Russian Federation)

    Objective: To develop a model for prediction of suicidal ideation or suicidal behaviour in Huntington disease gene expansion carriers (HDGEC) based on Enroll-HD data using…
  • 2018 International Congress

    Elevated serum α-synuclein levels in Huntington’s disease patients

    M. Breza, E. Emmanouilidou, G. Karadima, C.H. Kartanou, M. Panas, K. Vekrellis, G. Koutsis (Athens, Greece)

    Objective: To investigate serum α-synuclein levels in Huntington’s disease (HD) patients. Background: HD is a heredodegenerative disease caused by mutations in HTT coding for huntingtin…
  • 2018 International Congress

    Vertical and horizontal eye movements in a large cohort of early manifest Huntington’s disease: Evidence from ENROLL-HD

    W. Muller, M. MacAskill, L. Paermentier, T. Anderson (Christchurch, New Zealand)

    Objective: To determine, in a very large sample, how different types of eye movement are differentially impaired in early manifest HD, and determine whether vertical…
  • 2018 International Congress

    Cerebrospinal fluid proteomics reveals alterations of the renin-angiotensin system in Huntington’s disease

    V. Niemelä, J. Sundblom, A.M. Landtblom, D. Nyholm (Uppsala, Sweden)

    Objective: To identify new biomarkers of disease stage in HD. Background: Proteomic approaches for CSF studies in Huntington’s disease (HD) have so far yielded limited…
  • 2018 International Congress

    White matter microstructural alterations in Huntington Disease: When neurodegeneration starts?

    P. Azevedo, L. Piovesana, M. Nogueira, R. Guimarães, A. Amato Filho, F. Cendes, Í. Lopes-Cendes, C. Yasuda (Campinas, Brazil)

    Objective: The aim of our study is to characterize in detail the white matter (WM) microstructure alterations in Huntington Disease (HD) using the diffusion tensor…
  • « Previous Page
  • 1
  • …
  • 1272
  • 1273
  • 1274
  • 1275
  • 1276
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley